期刊文献+

超抗原-SE抗肿瘤作用的研究现状 被引量:5

Currrent stituation of Studies in Superantigen SE Antitumor Action
暂未订购
导出
摘要 综述了 SE抗肿瘤的作用机理、实验研究以及近年来的少量临床应用 .葡萄球菌肠毒素( SE)是一种外源性超级抗原 ,仅需微量即能高效地刺激 T细胞增殖 ,促使其产生大量和多种细胞因子及细胞毒 .提高机体总体细胞免疫水平 ,使之获得抗肿瘤的能力 .体外细胞水平和动物体内的研究结果表明 :SE能够产生强大的杀伤和抑制肿瘤细胞效应 ,故是一种很有前途的新型肿瘤免疫治疗剂 . Staphylococcal Enterotoxin(SE) is a foreign superantigen(SAg). Only in need of trace it may stimulated proliferating of T cell effectively;impel producing large scale or varied cytokine and cytotoxicity; increase human body immunity level of T cell and give capacity of antitumor. The study in the level of cell in vivo and in vitro shows:SE may produced powerful destructive and inhibited effect for tumor cell. So it is a new type of immunotherapy agents for tumor patients.Now it is applied in the treatment of tumor patients as well as the prevention of leucocytes decreasing after radiotherapy and chemotherapy and soothing other toxo vice reactions.Staphylococcal enterotoxin(SE) mechanism of antitumor function, laboratory research and a few of recent clinical application.
作者 鲍行豪 王毅
出处 《科技通报》 北大核心 2001年第2期62-66,共5页 Bulletin of Science and Technology
关键词 葡萄球菌肠毒素 超级抗原-SE 抗肿瘤作用 提升白细胞 肿瘤免疫治疗剂 化疗 毒副反应 staphylococcal enterotoxin superantigen antitumor action promoting leucocytes
  • 相关文献

参考文献4

二级参考文献3

共引文献4

同被引文献42

  • 1丛文铭,吴孟超,陈汉,张秀忠,董秀芬.DNA含量分析对复发性肝细胞癌克隆来源及其临床意义的初步研究[J].临床肝胆病杂志,1993,9(1):3-5. 被引量:26
  • 2姜永强.超抗原与肿瘤生物治疗[J].国外医学(肿瘤学分册),1996,23(5):257-260. 被引量:17
  • 3White J, Herman A, Pullen AM, et al. Vβ - specific superantigen staphylococcal enterotoxin B: stimulation of mature T-cell and clonal deletion in neonatal mice. Cell, 1989, 56:27 - 35.
  • 4Fischer H, Dohisten M, Andersson U, et al. Production of TNF-α and TNF-β by staphylococcal enterotoxin A activated human T-cell. J.Immunol. 1989, 144:4663-4669.
  • 5Dohlsten M, Sundstedt A, Bjorldund M, et al, Superantigen induce cytokines suppress growth of human colon-carcinoma cells, Int J Cancer 1993, 54:482-491.
  • 6Hedlund G, Dohlsten M, Petersson C, et al, Supetraantigen-based tumour therapy: in vivo activation of cytotoxin T-cell. Cancer Immunol.immunother. 1993, 36:38-42.
  • 7Hedlund G, Dohlsten M, Petersson C et al, Superantigen based tumor;In vivo activation of cytotoxic T-cell. Cance Immunother, 1993. 36:89 - 93.
  • 8Webb SR, Gascoigne NR. T-cell actiuation by superantigen[J]. Curr Opin Immunol,1994,6(5) :467-469.
  • 9Gintonio BT. Alpaugh RK. Schulty J . etal. Superantigen based immunotherapy[J]. J Clin Oncol, 1997,15(5): 1994 -1997.
  • 10(97)S-31.1997年第二季度新药品种公报[S].[S].中华人民共和国卫生部药政管理局,1997-6..

引证文献5

二级引证文献27

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部